Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
The once-weekly injectable, which gained unprecedented market traction for its weight-loss efficacy, is set to go off-patent in India later this week, opening the floodgates for cheaper generic alternatives
According to the SmPC, no dose adjustment is required for patients with renal or hepatic impairment, though clinical experience in severe impairment is limited and tolerability should be monitored
Unlike traditional sugars, which drive hunger through blood sugar spikes and crashes, Allulose appears to do the opposite
Reducing the release of glucagon, a hormone that increases blood sugar
Organizations that are covering GLP-1 drugs are using cost-control mechanisms such as utilization management (47%), annual maximums (40%), eligibility requirements (27%) and lifetime maximums (27%)
